Skip to main content

Geisinger Health

SEC CIK
0001946205
Latest filing
Aug 14, 2024

The latest 13F from Geisinger Health covers Q2 2024 (filed Aug 14, 2024): 5 long positions worth $344.1M. The top 10 holdings make up 100.0% of the portfolio, and the largest is iShares Core U.S. Aggregate Bond ETF at 43.2%. Livermore has 8 filings on Form 13F from this institution, going back to Q4 2022.

What changed in Q2 2024

Share counts compared with Q1 2024: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
1
Est. +$93.4M
Added
3
Est. +$2.82M
Reduced
1
Est. −$5.95M
Sold out
1
Est. −$103.3M

Top 5 holdings

Share of this quarter's portfolio value

  1. iShares Core U.S. Aggregate Bond ETF464287226
    43.2%$148.5M
  2. Invesco Exchange Traded FD T46137V357
    27.1%$93.4M
  3. iShares Tr464288513
    24.6%$84.6M
  4. iShares Core MSCI Emerging Markets ETF46434G103
    4.4%$15.1M
  5. iShares Tr464288877
    0.7%$2.54M

Share of portfolio

Each position's share of portfolio value

  1. iShares Core U.S. Aggregate Bond ETF43.2%
  2. Invesco Exchange Traded FD T27.1%
  3. iShares Tr24.6%
  4. iShares Core MSCI Emerging Markets ETF4.4%
  5. iShares Tr0.7%

Biggest buys

New and added positions, by estimated amount bought

  1. Invesco Exchange Traded FD T46137V357
    +$93.4MNew
  2. iShares Core U.S. Aggregate Bond ETF464287226
    +$1.36MAdded
  3. iShares Tr464288513
    +$1.32MAdded
  4. iShares Core MSCI Emerging Markets ETF46434G103
    +$142.3KAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Invesco Exchange Traded FD T46137V357
    +27.13 pp0.0% → 27.1%
  2. iShares Core U.S. Aggregate Bond ETF464287226
    +1.78 pp41.4% → 43.2%
  3. iShares Tr464288513
    +1.20 pp23.4% → 24.6%
  4. iShares Core MSCI Emerging Markets ETF46434G103
    +0.37 pp4.0% → 4.4%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. iShares Tr464287622
    −$103.3MSold out
  2. iShares Tr464288877
    −$5.95MReduced

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. iShares Tr464287622
    −28.79 pp28.8% → 0.0%
  2. iShares Tr464288877
    −1.69 pp2.4% → 0.7%

Metrics

13F metrics for Q2 2024, computed only from the numbers in the filings. Definitions below.

Portfolio value
$344.1M
−$14.7M (−4.1%) vs. prior quarter
Positions
5
0 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
27.4%
Q2 2024, one quarter
Average holding period
5.2 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2022), so positions held before then are understated.

13F filings by quarter

7 quarters, going back to Q4 2022. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $412.1M (Q4 2022)

Q4 2022: $412.1MQ1 2023: $411.8MQ2 2023: $312.4MQ3 2023: $295.2MQ4 2023: $319.5MQ1 2024: $358.8MQ2 2024: $344.1M
Q4 2022Q2 2024
13F filings of Geisinger Health by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2024Aug 14, 20245$344.1MiShares Core U.S. Aggregate Bond ETFInvesco Exchange Traded FD TiShares Trvs. Q1 2024SEC
Q1 2024May 15, 20245$358.8MiShares Core U.S. Aggregate Bond ETFiShares TriShares Trvs. Q4 2023SEC
Q4 2023Feb 13, 20245$319.5MiShares Core U.S. Aggregate Bond ETFiShares TriShares Trvs. Q3 2023SEC
Q3 2023Nov 9, 20234$295.2MiShares Core U.S. Aggregate Bond ETFiShares TriShares Trvs. Q2 2023SEC
Q2 2023Aug 11, 20235$312.4MiShares Core U.S. Aggregate Bond ETFiShares TriShares Trvs. Q1 2023SEC
Q1 2023May 12, 20235$411.8MiShares Core U.S. Aggregate Bond ETFiShares TriShares Trvs. Q4 2022SEC
Q4 2022Feb 23, 2023Amended5$412.1MiShares Core U.S. Aggregate Bond ETFiShares TriShares Core MSCI Eafe ETF–SEC